Dermapharm Holding SE (id:2642 DMP)
37.80 EUR
Opening hours: 09:00 - 17:30 (Central European Standard Time: 12/25/2024 4:25:38 PM)
Exchange open, closes in 1 hour 4 minutes
About Dermapharm Holding SE
Market Capitalization 2.05B
Dermapharm Holding SE, together with its subsidiaries, manufactures and sells off-patent branded pharmaceutical products in Germany. The company operates through three segments: Branded Pharmaceuticals and Other Healthcare Products, Parallel Import Business, and Herbal Extracts. It offers branded generics, OTC products, non-prescription healthcare products, and herbal extracts and parallel-imported originator pharmaceuticals. The company also provides vitamins, minerals, food supplements, as well as products for dermatology, allergology, pain and inflammation treatment, cardiovascular support, gynecology, and urology. In addition, it offers cosmetics and medical devices. Further, the company imports originator pharmaceuticals under the axicorp brand. It sells its products under the Dekristol, Keltican, Tromcardin, Ketozolin, bite away, Herpotherm, and epiivo brands. The company was founded in 1991 and is based in Grünwald, Germany. Dermapharm Holding SE operates as a subsidiary of Themis Beteiligungs-AG.
| Headquarters (address) |
Lil-Dagover-Ring 7 Grünwald 82031 Germany |
| Phone | 49 89 6 41 86 0 |
| Website | https://ir.dermapharm.de |
| Employees | 4K |
| Sector | Healthcare |
| Industry | Drug Manufacturers Specialty & Generic |
| Ticker | DMP |
| Exchange | Xetra Frankfurt Stock Exchange |
| Currency | EUR |
| 52 week range | 30.15 - 43.22 |
| Market Capitalization | 2.05B |
| Dividend yield forward | 9.31 % |
| Dividend yield forward Germany (ID:66, base:265) | 13.16 % |
| P/E trailing | 22.68 |
| P/E forward | 16.21 |
| Price/Sale | 1.79 |
| Price/Book | 3.80 |
| Beta | 1.14 |
| EPS | 1.68 |
| EPS Germany (ID:66, base:318) | 2.39 |
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Dermapharm Holding SE has raised their dividend 9.31 years in a row. This is below the 42132.506400 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Dermapharm Holding SE has raised their dividend 9.49 years in a row. This is below the 23.957000 year average in the 'Drug Manufacturers Specialty & Generic' industry
Payout Ratio
Payout Ratio: Dermapharm Holding SE has raised their dividend 57.14 years in a row. This is below the 148.467900 year average in the 'Drug Manufacturers Specialty & Generic' industry
Forward Annual Dividend Yield
Forward Annual Dividend Yield: Dermapharm Holding SE has raised their dividend 9.31 years in a row. This is below the 42132.506400 year average in the 'Drug Manufacturers Specialty & Generic' industry
Compound Average Growth Rate 3 Years
Compound Average Growth Rate 3 Years: Dermapharm Holding SE has raised their dividend 9.49 years in a row. This is below the 23.957000 year average in the 'Drug Manufacturers Specialty & Generic' industry
Payout Ratio
Payout Ratio: Dermapharm Holding SE has raised their dividend 57.14 years in a row. This is below the 148.467900 year average in the 'Drug Manufacturers Specialty & Generic' industry